Yep I read it all thoroughly and have some level of experience in this sector professionally! Not sure when I said I was "put off" lol! Significant clinical benefit in some of the markers. There is still a lot more to find out about the pharmacokinetics though. As I said, promising results (hence why I hold), but I still stand by my statement that the results alone are not conclusive enough to put a massive fire under the SP and I don't believe it will lead to short term deal of the numbers some people have been throwing around.
Not sure why you have to be so defensive about it, think my other comment was fairly moderate! Anyway, good luck to you! We are in the same boat, both hoping for the best outcome for Rett's patients and shareholders I am sure!
- Forums
- ASX - By Stock
- Ann: Trofinetide significant clinical benefit in Rett syndrome
Yep I read it all thoroughly and have some level of experience...
-
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$21.27 |
Change
0.650(3.15%) |
Mkt cap ! $2.718B |
Open | High | Low | Value | Volume |
$20.84 | $21.56 | $20.76 | $7.760M | 364.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1378 | $21.24 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$21.29 | 218 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 200 | 21.240 |
1 | 47 | 21.150 |
1 | 500 | 20.860 |
1 | 240 | 20.800 |
1 | 50 | 20.630 |
Price($) | Vol. | No. |
---|---|---|
21.300 | 12763 | 1 |
21.350 | 30 | 1 |
21.380 | 471 | 1 |
21.410 | 25 | 1 |
21.500 | 60 | 1 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online